These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6576127)

  • 1. Risk factors in phenytoin-induced gingival hyperplasia.
    Addy V; McElnay JC; Eyre DG; Campbell N; D'Arcy PF
    J Periodontol; 1983 Jun; 54(6):373-7. PubMed ID: 6576127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dilantin gingival hyperplasia: patient evaluation in relation to anticonvulsant dosage, degree of oral hygiene and extension of lesion].
    Pugliesi NS; da Silva FT; Saleh ER; Biagini VS; Marin de los Rios C; Rode Sde M
    Rev Faculdade Odontol FZL; 1989; 1(2):97-103. PubMed ID: 2485648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin as a risk factor in gingival hyperplasia.
    Perlík F; Kolínová M; Zvárová J; Patzelová V
    Ther Drug Monit; 1995 Oct; 17(5):445-8. PubMed ID: 8585105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measured effect of phenytoin withdrawal on gingival hyperplasia in children.
    Brunsvold M; Tomasovic J; Ruemping D
    ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic therapy and gingival considerations.
    Mégarbané JM
    Rev Dent Liban; 1974 Jun; 24(2):29-34. PubMed ID: 4608029
    [No Abstract]   [Full Text] [Related]  

  • 7. The gingival hyperplasia resulting from diphenylhydantoin in children and adults.
    Matsumoto K; Nakagawa K; Kaneko Z
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydantoin-induced hyperplasia].
    Korff M; Mutschelknauss R
    Dtsch Zahnarztl Z; 1973 Dec; 28(12):1157-63. PubMed ID: 4520580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histopathology of gingival manifestations of hydantoin therapy].
    Hanzély B
    Fogorv Sz; 1976; 69 Suppl():418-20. PubMed ID: 1071997
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factors involved in gingival hyperplasia caused by diphenyl hydantoin].
    Mattioli A; Mauro S; Menetti L; Orlando S
    Minerva Stomatol; 1997 Oct; 46(10):525-32. PubMed ID: 9432558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing phenytoin-induced gingival enlargement.
    Majola MP; McFadyen ML; Connolly C; Nair YP; Govender M; Laher MH
    J Clin Periodontol; 2000 Jul; 27(7):506-12. PubMed ID: 10914892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tooth health, drugs, and gingival hyperplasia].
    Munthe-Kaas A; Storhaug K
    Tidsskr Nor Laegeforen; 1978 Jan; 98(3):161-2. PubMed ID: 628914
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral hygiene and dental pathology due to hydantoin].
    Weinstein R; Romeo E; Zandonella Necca S; Giuccioli D; Cornaggia C
    Prev Assist Dent; 1986; 12(4):7-11. PubMed ID: 3095818
    [No Abstract]   [Full Text] [Related]  

  • 15. Dilantin hyperplasia: a preventable lesion?
    Hall WB
    Compend Suppl; 1990 Mar; (14):S502-5. PubMed ID: 2097043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phenytoin and gingival hyperplasia].
    Bostanci H; Aksoy N; Aydin N
    Ankara Univ Hekim Fak Derg; 1987 Sep; 14(3):313-6. PubMed ID: 3507874
    [No Abstract]   [Full Text] [Related]  

  • 17. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level.
    Kapur RN; Girgis S; Little TM; Masotti RE
    Dev Med Child Neurol; 1973 Aug; 15(4):483-7. PubMed ID: 4732898
    [No Abstract]   [Full Text] [Related]  

  • 18. Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy.
    Girgis SS; Staple PH; Miller WA; Sedransk N; Thompson T
    J Periodontol; 1980 Aug; 51(8):474-82. PubMed ID: 6931209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral hygiene status of epileptic patients under treatment with diphenyl hydantoin.
    Codipilly DP; Hoover JN
    Odontostomatol Trop; 1983 Dec; 6(4):223-7. PubMed ID: 6588372
    [No Abstract]   [Full Text] [Related]  

  • 20. The management of drug induced gingival hyperplasia in mentally retarded patients with hemophilia: a report of two cases.
    Murphy JB; Nersasian R; Clark A
    J Periodontol; 1978 Jan; 49(1):44-6. PubMed ID: 304480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.